Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Review · December 31, 2023

Tyrosine Kinase Inhibitors and Their Role in Treating Patients With Neovascular AMD or Diabetic Macular Oedema

Eye (London, England)


Additional Info

Eye (London, England)
Tyrosine Kinase Inhibitors and their role in treating neovascular age-related macular degeneration and diabetic macular oedema
Eye (Lond) 2023 Dec 01;37(18)3725-3733, S Chandra, EY Tan, T Empeslidis, S Sivaprasad

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading